Maria Calderon

Dr. Maria Calderon

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Science of The Total Environment
Verified
Journal Article
Closed access
Ariel BardachAriel Bardach
Ariel Bardach
ACAgustin Ciapponi
Agustin Ciapponi
NSNatalie Soto
Natalie Soto
MCMartin R. Chaparro
Martin R. Chaparro
MCMaria Calderon
Maria Calderon
MLMarta I. Litter
Marta I. Litter

1 December 2012 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
MCMaria Calderon
Maria Calderon
JGJuan Antonio Gálvez-Buccollini
Juan Antonio Gálvez-Buccollini
GCGloria Cueva
Gloria Cueva
COCarlos Ordoñez
Carlos Ordoñez
CBCarlos Bromley
Carlos Bromley
FFFabián Fiestas
Fabián Fiestas

1 November 2016 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
ACAgustin Ciapponi
Agustin Ciapponi
AAAndrea Alcaraz
Andrea Alcaraz
MCMaria Calderon
Maria Calderon
MMMaría Gabriela Matta
María Gabriela Matta
MCMartin Chaparro
Martin Chaparro
Ariel BardachAriel Bardach
Ariel Bardach

9 January 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MCMaria Calderon
Maria Calderon
GGGrace Gysin
Grace Gysin
AGAkash Gujjar
Akash Gujjar
AMAshleigh McMaster
Ashleigh McMaster
LKLisa King
Lisa King
BPBrendan Payne
Brendan Payne
Introduction: Understanding the proportion of patients with COVID-19 who have respiratory bacterial co-infections and the responsible pathogens is important for managing COVID-19 effectively while ensuring responsible antibiotic use. Objective: To estimate the frequency of bacterial co-infection in COVID-19 hospitalized patients and of antibiotic prescribing during the early pandemic period and to appraise the use of antibiotic stewardship criteria. Methods: Systematic review and meta-analysis was performed using major databases up to May 5, 2021. We included studies that reported proportion/prevalence of bacterial co-infection in hospitalized COVID-19 patients and use of antibiotics. Where available, data on duration and type of antibiotics, adverse events, and any information about antibiotic stewardship policies were also collected. Results: We retrieved 6,798 studies and included 85 studies with data from more than 30,000 patients. The overall prevalence of bacterial co-infection was 11% (95% CI 8% to 16%; 70 studies). When only confirmed bacterial co-infections were included the prevalence was 4% (95% CI 3% to 6%; 20 studies). Overall antibiotic use was 60% (95% CI 52% to 68%; 52 studies). Empirical antibiotic use rate was 62% (95% CI 55% to 69%; 11 studies). Few studies described criteria for stopping antibiotics. Conclusion: There is currently insufficient evidence to support widespread empirical use of antibiotics in most hospitalised patients with COVID-19, as the overall proportion of bacterial co-infection is low. Furthermore, as the use of antibiotics during the study period appears to have been largely empirical, clinical guidelines to promote and support more targeted administration of antibiotics in patients admitted to hospital with COVID-19 are required.

15 June 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
JMJenevieve Mannell
Jenevieve Mannell
SASafua Akeli Amaama
Safua Akeli Amaama
RBRamona Boodoosingh
Ramona Boodoosingh
Laura BrownLaura Brown
Laura Brown
MCMaria Calderon
Maria Calderon
CVCarla Cortez Vergara
Carla Cortez Vergara
Background: There has been substantial progress in research on preventing violence against women and girls (VAWG) in the last 20 years. While the evidence suggests the potential of well-designed curriculum-based interventions that target known risk factors of violence at the community level, this has certain limitations for working in partnership with communities in low- and middle-income (LMIC) countries, particularly when it comes to addressing the power dynamics embedded within north-south research relationships. Methods: As an alternative approach, we outline the study design for the EVE Project: a formative research project implemented in partnership with community-based researchers in Samoa and Amantaní (Peru) using a participatory co-design approach to VAWG prevention research. We detail the methods we will use to overcome the power dynamics that have been historically embedded in Western research practices, including: collaboratively defining and agreeing research guidelines before the start of the project, co-creating theories of change with community stakeholders, identifying local understandings of violence to inform the selection and measurement of potential outcomes, and co-designing VAWG prevention interventions with communities. Discussion: Indigenous knowledge and ways of thinking have often been undermined historically by Western research practices, contributing to repeated calls for better recognition of Southern epistemologies. The EVE Project design outlines our collective thinking on how to address this gap and to further VAWG prevention through the meaningful participation of communities affected by violence in the research and design of their own interventions. We also discuss the significant impact of the COVID-19 pandemic on the project in ways that have both disrupted and expanded the potential for a better transfer of power to the communities involved. This article offers specific strategies for integrating Southern epistemologies into VAWG research practices in four domains: ethics, theories of change, measurement, and intervention design. Our aim is to create new spaces for engagement between indigenous ways of thinking and the evidence that has been established from the past two decades of VAWG prevention research and practice.

1 December 2018 in Value in Health Regional Issues
Verified
Journal Article
Closed access
MCMaria Calderon
Maria Calderon
NMNicole Minckas
Nicole Minckas
SNSolange Nuñez
Solange Nuñez
ACAgustin Ciapponi
Agustin Ciapponi